Marcin Kurzyna: New NEJM Trial Evaluates Catheter-Directed Thrombolysis in PE
Marcin Kurzyna, Chairman-Elect of Working Group on Pulmonary Circulation and Right Ventricular Function at European Society of Cardiology, shared a post on LinkedIn about a recent article by Josef Kroupa et al, published in The New England Journal of Medicine, adding:
“The next landmark trial in the field of interventional treatment of pulmonary embolism is coming from Czechia!
Catheter-directed thrombolysis (without ultrasound) versus anticoagulation alone in intermediate-high-risk PE with some additional ‘red flags’ in a prospective, multicenter, open-label trial.
Mortality/morbidity combined endpoint driven by clinical deterioration, without differences in mortality, but 4 deaths (1.4 percent) in the AC group versus 1 in the CDT group (0.36 percent, p=NS).
Two intracranial bleedings in CDT group versus none in AC (p=NS), but without increase of major bleeding in the CDT cohort.
No evidence for a more extensive reduction in the RV/LV ratio after 48 h in the CDT group.
Big kudos and congratulations to Josef Kroupa and the whole group!
Presented at ESC Congress and published simultaneously in NEJM.”
Title: Catheter-Directed Thrombolysis in Intermediate-High–Risk Pulmonary Embolism
Authors: Josef Kroupa, Martin Radvan, Jan Mrozek, Martin Sluka, Stepan Jirous, Ota Hlinomaz, Milan Pliva, Jan Pudil, Hana Voberkova, Karolina Bartoskova, Martin Poloczek, Martin Kamenik, Michal Brabec, Eva Lichnerova, Martin Hutyra, Ivo Bernat, Martin Novak, Johana Horakova, Lucie Jelinkova, Tomas Knize, Petr Tousek, Cyril Stechovsky, Filip Varhanik, Zdenek Coufal, Jiri Jarkovsky, Viktor Kocka
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 1, 2026, 14:18Rafael Gomes: CoCAP Study Challenges Prolonged DAPT After CABG
-
Sep 1, 2026, 09:16Nicolas Gendron: Real-World Data on Danaparoid in Patients with Suspected HIT
-
Sep 1, 2026, 08:24Cristina Chang: The Importance of The New ET Treatments
-
Sep 1, 2026, 07:22Abdul Mannan: ASH 2026 Guidelines – New Treatment Approach for Adult ITP
-
Sep 1, 2026, 07:20Alejandro González Veliz: Silent Atherosclerosis Starts Earlier Than We Think
-
Sep 1, 2026, 07:18Alan Nurden: A New Mechanism Behind Immune Thrombocytopenia
-
Sep 1, 2026, 07:18Susan Shea: New NHLBI Fellowship Supports Thrombinflammation Research
-
Sep 1, 2026, 07:12Sriraman Punniakoti: Pediatric ALL Therapy and Cerebrovascular Thrombosis
-
Sep 1, 2026, 07:04Piotr Czempik: ROTEM in Sepsis-Related Coagulopathy